Clavesin 1 Antikörper (N-Term)
Kurzübersicht für Clavesin 1 Antikörper (N-Term) (ABIN2785317)
Target
Alle Clavesin 1 (CLVS1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- RLBP1L1 Antibody - N-terminal region
-
Sequenz
- NFKADDPGIK RALIDGFPGV LENRDHYGRK ILLLFAANWD QSRNSFTDIL
-
Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 79%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against RLBP1L1. It was validated on Western Blot using a cell lysate as a positive control.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human RLBP1L1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
We also sell a specific blocking peptide that can be used in combination with this antibody. You can find the blocking peptide under AAP53266-100UG
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- prevent freeze-thaw cycles
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
-
- Clavesin 1 (CLVS1)
-
Andere Bezeichnung
- RLBP1L1
-
Hintergrund
-
Background Information: RLBP1L1 contains 1 CRAL-TRIO domain. It may be used as a marker for human hepatocellular carcinomas.
Gene Name: Clavesin 1
Alternative Symbols: CRALBPL, RLBP1L1, C6orf212L
Protein Name: Clavesin-1
-
Molekulargewicht
- 41kDa
-
Gen-ID
- 157807
-
NCBI Accession
- NP_775790
-
UniProt
- Q8IUQ0
Target
-